A small 30-patient, one-year confirmatory clinical trial in Japanese patients that compares NeoCart to microfracture
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders; Knee injuries
- Focus Registrational; Therapeutic Use
- Sponsors Histogenics Corporation
- 15 Mar 2018 According to an Histogenics Corporation media release, Histogenics is working closely with MEDINET on the development of NeoCart for the Japanese market and both companies intend to work on the preparation of a clinical trial notification to support this planned trial in Japan in the second half of 2018.
- 21 Dec 2017 According to a Histogenics Corporation media release, MEDINET and Histogenics went under a collaboration aggrement for develpment and commercialization of NeoCart in Japanese market.
- 17 Aug 2017 New trial record